These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2481537)

  • 21. [Differences in therapeutic strategies for adult leukemia and lymphoma between Japan and western countries].
    Sakamaki H
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):41-8. PubMed ID: 9987496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
    Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
    N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aspects of molecular remission in hematology and oncology].
    Novik AA; Kamilova TA; Tsygan VN
    Vopr Onkol; 2001; 47(3):270-7. PubMed ID: 11544823
    [No Abstract]   [Full Text] [Related]  

  • 24. [Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
    Huang X; Chen Y; Han W; Chen Y; Hong H; Lu D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 35(2):115-8. PubMed ID: 12920822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
    Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
    Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukemia and myelomatosis.
    Catovsky D
    Cancer Chemother Biol Response Modif; 1987; 9():134-64. PubMed ID: 3079401
    [No Abstract]   [Full Text] [Related]  

  • 28. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
    Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
    Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.
    Bortin MM; Horowitz MM; Gale RP; Barrett AJ; Champlin RE; Dicke KA; Gluckman E; Kolb HJ; Marmont AM; Mrsic M
    JAMA; 1992 Aug; 268(5):607-12. PubMed ID: 1321298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allogeneic bone marrow transplantation for the treatment of leukemia.
    Lu DP; Guo NL; Jin NR; Zheng H; Lu XJ; Shi Q; Shan FX; Jiang B; Tang H; Liu MY
    Chin Med J (Engl); 1990 Feb; 103(2):125-30. PubMed ID: 2118028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB).
    Akatsuka Y; Kodera Y; Yamamoto K; Minami S; Miyamura K; Morishita Y; Morishima Y; Saitoh H; Horibe K; Yamauchi T
    Int J Hematol; 1992 Jun; 55(3):249-53. PubMed ID: 1498315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
    Huang H; Lin M; Meng H
    Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.
    Anasetti C; Hansen JA
    Transfus Sci; 1994 Sep; 15(3):221-30. PubMed ID: 10155543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow transplantation in children.
    Pick TE
    Crit Rev Oncol Hematol; 1988; 8(4):311-37. PubMed ID: 3064935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukemias and myeloma.
    Wiernik PH
    Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
    [No Abstract]   [Full Text] [Related]  

  • 37. French national bone marrow donor registry and interaction with foreign files.
    Raffoux C; Rabian C; Gluckman E
    Nouv Rev Fr Hematol (1978); 1989; 31(2):167-9. PubMed ID: 2671929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
    Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
    Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of KIR2DS4 and its variant KIR1D with leukemia.
    Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
    Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
    [No Abstract]   [Full Text] [Related]  

  • 40. Current status of bone marrow transplantation.
    Bortin MM; Horowitz MM
    Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.